MU — Enhanced Equity Research

Executive Summary

A memory supercycle re-rates Micron into a trillion-dollar AI-infrastructure compounder

Micron (MU) has been the single biggest beneficiary of the AI-memory supercycle, vaulting from a 52-week low of $103.38 to a recent $1,132.33 and a ~$1.27T market cap. The Q3 FY2026 print on June 24 was extraordinary: revenue rose +346% YoY to a record $41.5B (vs ~$35.7B est.), non-GAAP EPS hit $25.11 (vs $20.49 est.), and non-GAAP gross margin reached 84.9%. Management guided Q4 to $50B ± $1B at ~86% gross margin, with adjusted free cash flow expected to exceed $30B. The durability case is unusually strong for a memory name: HBM3E and HBM4 are fully booked through 2027 with demand into 2028, and Micron has locked in $22B of strategic customer agreements including $18B of cash deposits — long-term agreements that blunt the historic boom-bust cyclicality. The bull-case tension is valuation regime change: the stock trades at only ~8-10x forward earnings (FY27E EPS ~$97-112), so the multiple is cheap, but the risk is that consensus is extrapolating a cyclical peak. Sell-side is overwhelmingly bullish (~Strong Buy, 41% Strong Buy / 55% Buy, avg PT ~$1,294-1,410) with UBS at $1,625 and Barclays at $2,000. We initiate BUY with a $1,333 weighted target, sizing into pullbacks given a ~3x beta and a stock that just fell ~7% in a single session.

FUNDAMENTAL METRICS

AI-memory supercycle turns Micron into a cash machine — Q3 FY2026 revenue exploded +346% YoY to a record $41.5B at an 84.9% non-GAAP gross margin — HBM3E/HBM4 are fully booked through 2027 and Q4 is guided to $50B with ~86% margins.

Q3 FY2026 Revenue

$41.5B

+346% YoY · record

Q3 Non-GAAP EPS

$25.11

vs $20.49 est. · +22.6%

Q3 Non-GAAP Gross Margin

84.9%

Op. margin 81.2%

Q4 FY2026 Rev Guide

$50.0B ±$1B

Gross margin ~86%

Cash & Investments

$30.2B

Debt cut $4.4B in Q3

Adj. Free Cash Flow (Q3)

$18.3B

Q4 FCF expected >$30B

Strategic Agreements

$22B

Incl. $18B cash deposits

Forward P/E

~8-10x

FY27E EPS ~$97-112

Quarterly Revenue — Trailing 4 Quarters

$11.3B

Q4 2025

$15.7B

Q1 2026

$25.6B

Q2 2026

$41.5B

Q3 2026

GROWTH & CATALYSTS

HBM is sold out through 2027 and long-term agreements are killing the old memory cycle

+346%

Q3 FY2026 Revenue Growth

Record $41.5B

$22B

Strategic Customer Agreements

$18B cash deposits secured

~$45B+

FY2027 Planned Capex

Up from ~$27B in FY2026

Dec 17, 2025

Q1 FY2026 Earnings

EPS $4.78 vs $3.94 est. — beat, as DRAM/HBM demand from AI data centers began outrunning supply.

Mar 2026

Q2 FY2026 Earnings

Non-GAAP EPS $12.20 vs $8.79 est. (+38.6% beat) on record revenue; pricing inflected sharply as memory tightened.

Jun 24, 2026

Record Q3 FY2026 Print

Revenue $41.5B (+346% YoY), EPS $25.11, 84.9% gross margin; Q4 guided to $50B / ~86% GM. Shares jumped ~14.6% after-hours; dividend declared.

Jun 25-26, 2026

PT Hikes & Profit-Taking

UBS to $1,625, Barclays to $2,000, Goldman to $1,100 (Neutral). Stock then fell ~6.7% to $1,132 on a pivot-top pullback.

Through 2027-28

HBM Booked Out

HBM3E/HBM4 fully booked through 2027 with demand into 2028; HBM4E ramps in CY2027 on the 1-gamma node — the multi-year visibility the bull case rests on.

Earnings & Signals

Forward Estimates, Surprises & Insider Activity

Forward Earnings Estimates

FY+1 EPS Consensus~$34 (FY2026E non-GAAP, est.)

FY+2 EPS Consensus~$97-112 (FY2027E, ~+185-230% YoY)

PEG Ratio~0.05-0.18 — extremely low; explosive near-term EPS growth dwarfs the multiple (peak-cycle caveat applies)

Forward P/E~8-10x on FY2027E EPS; ~33x on FY2026E EPS — cheap versus growth but reflects cyclical-peak skepticism

EPS Revisions (90d)↑30 ↓0 (Strongly positive — FY27 EPS revised up to ~$112 from ~$90 in March; near-unanimous upward revisions after the record Q3 print)

Guidance AccuracyExcellent — beat and raised in all three FY2026 quarters; Q3 revenue beat ~16% and Q4 guide ($50B/~86% GM) came in well above the Street

Earnings Surprise Track Record

Q3 FY2026 Est: $20.49 Act: $25.11 +22.6%

Q2 FY2026 Est: $8.79 Act: $12.20 +38.6%

Q1 FY2026 Est: $3.94 Act: $4.78 +21.3%

Q4 FY2025 Est: ~$2.85 Act: ~$3.03 (est.) +6%

Beat Rate4 of 4 quarters beat (100%)

Insider Activity (90 Days)

Net Buying/SellingNet selling (~$27.1M sold over trailing 30 days; no open-market buys)

Sell/Buy RatioSell-only — ~49.6K shares sold, 0 bought in the last 30 days

Mildly cautious but unsurprising. With the stock up ~10x off its low, routine insider selling (largely 10b5-1 and option-exercise driven) is expected and not a strong negative signal. The absence of open-market buying is typical at all-time-high valuations and does not contradict the bullish operating story.

Trailing-30-day insider sales totaled ~$27.1M across ~49.6K shares with no purchases — consistent with profit-taking and scheduled dispositions rather than a fundamental warning.

Peer Comparison

Relative Valuation vs. Competitors

Company	P/E (fwd)	EV/Rev	Rev Growth	Gross Margin
Micron	~8-10x	~7-8x	+346%	84.9%
SK Hynix	~5.9x	~4x	strong	~60-72%
Samsung Elec.	~5.5x	~1.5x	strong	~40%+
SanDisk	~12.4x	~3x	+82.8%	~56%

Micron's Q3 FY2026 gross margin of 84.9% now exceeds even HBM leader SK Hynix and dwarfs SanDisk (~56%) and Western Digital (~50%), reflecting the DRAM/HBM mix at the heart of the AI buildout. Yet MU trades at only ~8-10x forward earnings — a premium to the Korean memory giants (SK Hynix ~5.9x, Samsung ~5.5x) but cheap versus the ~+346% revenue growth and the record cash generation. The key debate is not relative cheapness but cyclicality: peers carry low multiples precisely because the market discounts peak memory earnings. Micron's $22B of long-term agreements and HBM booked through 2027 are the differentiator that could justify a higher, more durable multiple than past cycles allowed.

Valuation

Price Targets & Scenarios

Scenario	Price Target	Assumptions	Probability
Supercycle Extends to 2028+	$1,650	AI-memory supply stays tight into 2028, HBM4/HBM4E ramps lift mix and margins above 85%, long-term agreements convert in full, and FY27E EPS reaches the ~$110+ high end. A modest 14-15x re-rating on rising earnings drives the move; tracks UBS/Barclays bullish targets.	35%
Durable but Cooling Supercycle	$1,300	Demand stays robust through 2027 but pricing growth decelerates as supply catches up; FY27E EPS lands near the ~$97 consensus and the multiple holds at ~12-13x. Lands near the ~$1,294 consensus mean PT.	45%
Cyclical Peak / Pricing Roll-Over	$850	Memory pricing peaks in late 2026, capacity additions from Samsung/SK Hynix re-introduce oversupply, AI-capex digestion hits demand, and the market re-applies a trough cyclical multiple to peak earnings. Reverts toward the 200-day MA region.	20%

Probability-Weighted Target: $1,333 (~18% upside vs $1,132.33)

$1,333

Weighted

Bull $1,65035%

Base $1,30045%

Bear $85020%

Analyst Consensus

UBS

$1,625

Buy

Goldman Sachs

$1,100

Neutral

Morgan Stanley

$1,050

Overweight

Citigroup

$840

Buy

Strong Buy consensus — ~41% Strong Buy / 55% Buy / 3% Hold / 0% Sell across ~29-43 analysts. Avg 12-mo PT clusters ~$1,294-1,410 (high $2,000 Barclays, lows ~$840 Citi), implying ~14-25% upside from $1,132.33. Targets were raised sharply after the record Q3 print and $50B Q4 guide.

Technical

Key Levels & Options Intelligence

S/RSupport & Resistance

52-Week High

$1,255.00

Near-Term Resistance

$1,213.56

Current Price (Jun 26, 2026)

$1,132.33

Primary Support

$1,119.25

Secondary Support

$924.00

50-Day Moving Avg

$732.80

200-Day Moving Avg

$360.85

OptOptions & Sentiment

RSI (14): ~66 — upper-neutral, approaching overbought after the post-earnings surge but not extreme
Moving Averages: Strong Buy — price far above the 50-day ($732.80) and 200-day ($360.85); short-term MA well above long-term, a textbook uptrend
Implied Volatility (30d): ~76-108% — elevated; options priced a ~±11% move into Q3 earnings at ~155% front-month IV
Put/Call Ratio (Volume): ~0.91 — roughly balanced, leaning slightly call-heavy / bullish; pre-earnings runs hit 1.5-2.2 calls per put
Put/Call Ratio (Open Interest, 90d): ~1.44 — put-skewed in OI, reflecting hedging against the parabolic run
Beta: ~3.0 — high; MU trades as a high-torque proxy on AI-capex and memory-pricing sentiment
Recent Action: Pivot-top sell signal Jun 25; stock fell ~6.7% Jun 26 to $1,132 on profit-taking after the +14.6% earnings pop
Daily Volatility: ~8% — large intraday swings common at these levels given the high beta and elevated IV

Conviction Analysis

Systematic Conviction Score: 82/100 (High)

Analyst Alignment

30%

FCF Visibility

25%

Catalyst Clarity

20%

Valuation Safety

15%

Mgmt Quality

10%

Near-unanimous Strong Buy sell-side (analyst alignment 90), record and highly visible free cash flow with HBM booked through 2027 and $18B in customer cash deposits (FCF visibility 85), and clear multi-quarter catalysts (catalyst clarity 80) drive a weighted score of 82 — High conviction. The main offset is valuation safety (70): the headline multiple is cheap, but it sits on potentially peak cyclical earnings, so the BUY is sized to accumulate into volatility rather than chase the high.

Risk & Ownership

Risk Assessment & Insider Signals

!Risk Factors

Cyclical Peak / Memory Pricing Roll-Over: Memory is historically boom-bust. Today's 84.9% gross margins and +346% growth sit at or near a cyclical peak. If DRAM/NAND/HBM pricing rolls over as Samsung and SK Hynix add capacity, earnings could fall sharply and the market would re-apply a trough multiple to declining EPS — the classic memory de-rating.
Competitive HBM Supply from SK Hynix & Samsung: SK Hynix leads HBM with ~58% share and Samsung ~21%; both are aggressively expanding HBM4 capacity. If rivals close the technology/yield gap or flood capacity, Micron's pricing power and ~85% margins compress, eroding the premium the stock now commands.
AI-Capex Digestion: Demand is anchored to hyperscaler AI infrastructure spend. Any pause or digestion phase in AI capex (cloud capex cuts, ROI scrutiny on large models) would hit memory bit demand quickly, given MU's high operating leverage and ~3x beta.
Capital Intensity & Execution: FY2027 capex is guided to exceed the mid-$40B range (up from ~$27B in FY2026). Massive fab buildout, HBM4E ramp on the 1-gamma node, and packaging scale-up carry yield and timing risk; execution slippage would dent the supply Micron has already sold forward.
Valuation / Sentiment Reversal: The stock has risen ~10x off its 52-week low to a ~$1.27T cap. Even at a low headline P/E, sentiment is euphoric (Barclays $2,000). A high-beta name this extended can correct hard on any disappointment — it already fell ~6.7% in a single post-earnings session.
Geopolitical & China Exposure: Memory is exposed to US-China trade tensions, export controls, and the prior China cybersecurity restrictions on Micron products. Escalation could limit addressable market or disrupt supply chains and customer access.

OOwnership & Insider Signals

Institutional Ownership: Institutions hold ~80.5% of shares outstanding and have broadly been adding into the rally — a high-quality, index-and-active-driven base.
Vanguard Group: Largest holder at ~84.3M shares, ~7.47% of common stock (as of Mar 31, 2026); has been adding to the position.
BlackRock: ~85.9M shares, ~7.8% ownership; like Vanguard, increasing rather than trimming exposure.
Insider Ownership: Management insiders hold ~0.29% (~3.3M of ~1.13B shares). CEO Sanjay Mehrotra owns ~1.07M shares; EVP Manish Bhatia ~323K; GC Joel Poppen ~259K.
Share Count & Market Cap: ~1.13B shares outstanding; market cap ~$1.27T as of late June 2026 — Micron has crossed into trillion-dollar territory on the AI-memory re-rating.
Capital Return: Micron declared a dividend alongside Q3 results and is de-levering (debt cut $4.4B in Q3), supported by Q4 FCF expected to exceed $30B — a shift toward shareholder returns atop the growth story.

Recommendation

Summary

Rating

BUY

Conviction

High

Price Target

$1333

Timeframe

12 mo

Upside

+18%

Position Size

4%-6%

Entry Strategy

Tranche 1 — 40%

~$1,130

Initial position near current price, above primary support at $1,119.25. Start measured given the parabolic run and ~3x beta.

Tranche 2 — 35%

~$1,000

Add on a normal-course pullback toward the round number / gap-fill zone between primary and secondary support.

Tranche 3 — 25%

~$900

Final tranche reserved for a deeper flush toward secondary support ($924) — a high-conviction add if the supercycle thesis stays intact through Q4 results.

MU